Logotype for Virbac SA

Virbac (VIRP) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Virbac SA

H1 2025 earnings summary

8 Jul, 2026

Executive summary

  • Revenue for H1 2025 reached €738.3 million, up 5.0% year-over-year, with 5.6% organic growth at constant rates and scope, driven by both volume and price increases; Sasaeah acquisition in Japan contributed 2.2 points to growth.

  • EBIT adjusted was €135 million (18.3% of revenue), down 2.4 points YoY at constant exchange rates, mainly due to temporary and calendar effects, higher inventory write-offs, and production shutdowns.

  • Net result was €82.2 million, down from €94.9 million in HY24, reflecting EBIT evolution, increased financial costs, and FX impacts.

  • Strong performance in Americas, Europe, EMEA, and Far East Asia, with Mexico, USA, and India as top contributors; Pacific region declined due to Australia.

  • New CEO Paul Martingell appointed, effective September 1, 2025; Habib Ramdani returns to CFO and deputy CEO roles.

Financial highlights

  • Net revenue grew 5.6% at actual rates, with a 7.8% rise at constant exchange rates, excluding the positive impact of the Sasaeah acquisition in Japan.

  • EBIT adjusted margin was 18.3%, down from 21.4% YoY, mainly due to increased write-offs and temporary site closure for maintenance.

  • Net debt increased to €201.4 million, mainly due to CapEx, working capital needs, and seasonality; net debt/EBITDA ratio remains significantly below 1.

  • CapEx nearly doubled YoY to €53.9 million, exceeding €50 million in H1, with full-year 2025 and 2026 expected above €100 million due to industrial transformation projects.

  • Net free cash flow was -€41.1 million, reflecting higher capex and working capital needs.

Outlook and guidance

  • Full-year 2025 guidance confirmed: net revenue growth of 4%-6% at constant rates and scope (5%-7% including Sasaeah), EBITDA margin around 16% at constant FX, and net debt evolution as previously guided.

  • Targeting 20% EBIT adjusted margin by 2030, with no change to this ambition.

  • Sasaeah acquisition expected to add 1 point to 2025 growth and be neutral on EBITA ratio.

  • Cash position projected to improve by €80 million in 2025, excluding acquisitions.

  • Moderate impact anticipated from US customs tariffs, with most US revenue shifting to local production.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more